federal_register: E9-29875
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E9-29875 | Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc. The supplemental NADA adds Mycoplasma bovis to the bovine respiratory disease pathogens for which florfenicol injectable solution is approved as a treatment. | 2009-12-16 | 2009 | 12 | https://www.federalregister.gov/documents/2009/12/16/E9-29875/implantation-or-injectable-dosage-form-new-animal-drugs-florfenicol | https://www.govinfo.gov/content/pkg/FR-2009-12-16/pdf/E9-29875.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc. The supplemental NADA adds Mycoplasma bovis to the bovine respiratory... |